265 related articles for article (PubMed ID: 9719587)
1. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
Liu ZD; Khodr HH; Lu SL; Hider RC
J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
[TBL] [Abstract][Full Text] [Related]
6. Amido-3-hydroxypyridin-4-ones as iron(III) ligands.
Piyamongkol S; Ma YM; Kong XL; Liu ZD; Aytemir MD; van der Helm D; Hider RC
Chemistry; 2010 Jun; 16(21):6374-81. PubMed ID: 20397153
[TBL] [Abstract][Full Text] [Related]
7. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
Dehkordi LS; Liu ZD; Hider RC
Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
Liu ZD; Liu DY; Lu SL; Hider RC
J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
Ma Y; Roy S; Kong X; Chen Y; Liu D; Hider RC
J Med Chem; 2012 Mar; 55(5):2185-95. PubMed ID: 22339047
[TBL] [Abstract][Full Text] [Related]
10. Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.
Zhou T; Neubert H; Liu DY; Liu ZD; Ma YM; Kong XL; Luo W; Mark S; Hider RC
J Med Chem; 2006 Jul; 49(14):4171-82. PubMed ID: 16821777
[TBL] [Abstract][Full Text] [Related]
11. A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
Santos MA; Gama S; Gil M; Gano L
Hemoglobin; 2008; 32(1-2):147-56. PubMed ID: 18274992
[TBL] [Abstract][Full Text] [Related]
12. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
Liu G; Men P; Kenner GH; Miller SC; Bruenger FW
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):599-611. PubMed ID: 15113026
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
Liu ZD; Liu DY; Lu SL; Hider RC
Arzneimittelforschung; 2000 May; 50(5):461-70. PubMed ID: 10858874
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
Zhou T; Kong XL; Liu ZD; Liu DY; Hider RC
Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
Moridani MY; Tilbrook GS; Khodr HH; Hider RC
J Pharm Pharmacol; 2002 Mar; 54(3):349-64. PubMed ID: 11902801
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
[TBL] [Abstract][Full Text] [Related]
17. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
Kontoghiorghes GJ
Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
[TBL] [Abstract][Full Text] [Related]
18. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
Zanninelli G; Choudury R; Loréal O; Guyader D; Lescoat G; Arnaud J; Verna R; Cosson B; Singh S; Hider RC; Brissot P
J Hepatol; 1997 Jul; 27(1):176-84. PubMed ID: 9252093
[TBL] [Abstract][Full Text] [Related]
19. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
Gama S; Gil M; Gano L; Farkas E; Amélia Santos M
J Inorg Biochem; 2009 Feb; 103(2):288-98. PubMed ID: 19091421
[TBL] [Abstract][Full Text] [Related]
20. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
